ADRB2 and ovarian carcinoma: The article with the strongest citation burst was published in Nature Medicine in 2006, which demonstrated that in ovarian cancer (22), beta-2-adrenergic receptor (β2-AR) activation mediated by chronic stress promotes tumor growth and angiogenesis, consistent with the results of the study by Sood et al.